Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Jan 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.6B | 1.6B | 1.5B | — |
| Cost of revenue | 154M | 147M | 140M | — |
| Gross profit | 1.5B | 1.4B | 1.4B | — |
| Operating expense | ||||
| Research & development | 393M | 378M | 368M | — |
| Selling general and admin | 699M | 686M | 641M | — |
| Other operating expenses | — | — | — | — |
| Operating income | 381M | 346M | 343M | — |
| Non operating interest income | ||||
| Income | — | — | 11M | — |
| Expense | — | — | — | — |
| Other income expense | -13M | -3M | -2M | — |
| Pretax income | 372M | 351M | 352M | — |
| Tax provision | 69M | 76M | 70M | — |
| Net income | 303M | 275M | 282M | — |
| Basic EPS | — | 1.3 | 1.3 | 1.3 |
| Diluted EPS | — | 1.3 | 1.3 | 1.3 |
| Basic average shares | — | 215M | 216M | 214M |
| Diluted average shares | — | 217M | 217M | 216M |
| EBITDA | 440M | 397M | 393M | — |
| Net income from continuing op. | 303M | 275M | 282M | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |